Medical News

RSS

Update on SOKO Fitness & Spa Group's recently broadened geographic expansion strategy

SOKO Fitness & Spa Group, Inc. ("SOKO" or the "Company"), an operator of fitness centers, beauty salons and spas in Northeast China as well as suburban Beijing, today provided an update on its recently broadened geographic expansion strategy.

10 Feb 2010

Goodwin Biotechnology, Macrocyclics announce collaboration on Chelation and Bioconjugation

Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation. The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.

10 Feb 2010

CMA launches Physician Assistant Toolkit

The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).

10 Feb 2010

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.

10 Feb 2010

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Luth Research's IndicatorEDG survey finds Americans are less likely to feel their dreams are attainable. Back in the third quarter of 2006, 62% of Americans said they had an excellent, very good or good chance of achieving their personal dreams.

10 Feb 2010

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13.

10 Feb 2010

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

10 Feb 2010

UnitedHealth Group pays annual dividend to shareholders; renews Share Repurchase Program

UnitedHealth Group (NYSE:UNH) announced today that its Board of Directors, at its regular meeting on February 9, 2010, authorized payment of an annual dividend to shareholders for 2010.

10 Feb 2010

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening. The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.

10 Feb 2010

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.

10 Feb 2010

NeuroMetrix announces 2009 fourth quarter financial results

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.

10 Feb 2010

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into a collaboration and license agreement with Alexza Pharmaceuticals, Inc.

10 Feb 2010

BioClinica reports financial results for quarter and year ended December 31, 2009

BioClinica™, Inc., a global provider of clinical trial services, today announced its financial results for the quarter and year ended December 31, 2009. The operating results of Phoenix Data Systems (“PDS”) are included in the financial results following the acquisition of PDS that was completed March 24, 2008.

From Clario 10 Feb 2010

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 second quarter, ended December 31, 2009.

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive injectable MS medications through a community pharmacy.

10 Feb 2010

ISR’s report identifies challenges faced by industry while recruiting participants in clinical trails

Industry Standard Research (ISR Reports) today announced the launch of a substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.

10 Feb 2010

Contraceptive sex education and 'empowerment' for ten-year-old children

International Planned Parenthood Foundation's recently released report, "Stand and Deliver: Sex, Health and Young People in the 21st Century," advocates policies that jeopardize the well-being of children's health, the importance of parents and the moral values of our society, Family Research Council said today.

10 Feb 2010

Researchers find differences in the biology of lung cancer between men and women

An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a study in the February 10 issue of JAMA.

10 Feb 2010

ONA warns nursing cuts may result in longer wait times for cancer patients

The Ontario Nurses' Association (ONA) is warning that London-area cancer patients will face longer wait times as London Health Sciences Centre cuts five of its 22 full-time and four of its part-time front-line primary care nurses providing outpatient cancer program care.

10 Feb 2010

Medical News

Update on SOKO Fitness & Spa Group's recently broadened geographic expansion strategy

Goodwin Biotechnology, Macrocyclics announce collaboration on Chelation and Bioconjugation

CMA launches Physician Assistant Toolkit

Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

UnitedHealth Group pays annual dividend to shareholders; renews Share Repurchase Program

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

NeuroMetrix announces 2009 fourth quarter financial results

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

BioClinica reports financial results for quarter and year ended December 31, 2009

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

ISR’s report identifies challenges faced by industry while recruiting participants in clinical trails

Contraceptive sex education and 'empowerment' for ten-year-old children

Researchers find differences in the biology of lung cancer between men and women

ONA warns nursing cuts may result in longer wait times for cancer patients

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News